arrow
drop
search
cross
Select login type
x
My Account Login
Working Group's Member Login
CHOOSE A PAGE TO ACCESS
x
WGXI Patient Involvement: Workplans, drafts, TC notes ...
WGXI Patient Involvement: Background Documents
WGXI Patient Involvement: Face-to-face meetings
WGXII Benefit-risk Working Group Documents
WGXII Benefit-risk Working Group Documents
WGXIII Real-world Data Working Group Documents
SCAR Working Group Documents
Educational Standards Working Group Documents
Good Governance Practice for Research Institutions Working Group Documents
Pharmacoepidemiology for Public Health Working Group Documents
MedDRA Labelling Groupings Working Group Documents
Clinical Research in Resource-limited Settings Working Group Documents
Login
MENU
Login
Areas of work
Bioethics
Pharmacovigilance
Product Development
Publications
Recent
Translations
Earlier
All
Working groups
Working Group XV – Pharmacoepidemiology for Public Health
Working Group XIV Artificial Intelligence in Pharmacovigilance
Educational Standards
Severe Cutaneous Adverse Reactions – SCAR
Working Group XII – Benefit-Risk Balance for Medicinal Products
Future Working Groups
Former Working Groups
Events & Training
Online training
Webinars
Meetings & Conferences
Students
Annual Award
About cioms
Contact
About
Our History
Governance
Executive committee
Collaborations
News
Newsletters
CIOMS in the media
Membership
CIOMS Members
Invoice Payment
search
CIOMS in the media
Home
CIOMS in the media
TIMELINE:
2024
2023
2022
2021
2020
2019
2018
2017
05/01
2024
American Journal of Bioethics
Which Benefits Can Justify Risks in Research?
more
08/01
2024
F1000Research
The readiness of the Asian research ethics committees in responding to the COVID-19 pandemic: A multi-country survey
[awaiting peer review]
more
10/01
2024
Wellcome Open Research
Strengthening global health policies, guidance, regulations: responding to calls for public consultation by integrating diverse voices, experience and expertise
[awaiting peer review]
more
16/01
2024
Clinical Therapeutics
The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance
more
01/02
2024
Journal of Law and the Biosciences
Purpose definition as a crucial step for determining the legal basis under the GDPR: implications for scientific research
more
07/02
2024
Regulatory Focus
Regulators, industry tout new approach for benefits-risk assessments
more
09/02
2024
Therapeutic Advances in Drug Safety
The 7th European Pharmacovigilance Congress: speaker abstracts
more
1 of 7
1
2
3
…
7
Next »
Hit enter to search or ESC to close
